BioAdaptives, Inc.

BDPT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Assets
Cash & Equivalents $29.2K $73.6K $215.2K $59.3K $210.6K $39.6K $261.9K $43.9K
Accounts Receivable — — — — — — — —
Inventory $36.0K $43.0K $44.7K $44.2K $39.6K $40.6K $19.1K $0
Total Current Assets $67.8K $123.4K $211.9K $108.9K $255.5K $110.4K $261.9K $46.4K
Property, Plant & Equipment $11.0K $12.5K $14.0K $15.5K $17.0K — $0 —
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — $14.0K — — — $0 $0
Total Assets $78.8K $135.9K $225.9K $124.4K $272.5K $110.4K $261.9K $46.4K
Liabilities
Accounts Payable $268.8K $248.9K $232.7K $230.8K $204.1K $196.8K $179.5K $473.5K
Total Current Liabilities $1.8M $2.3M $2.4M $1.6M $1.4M $1.7M $1.7M $1.9M
Long-Term Debt — — — — — — — —
Total Liabilities $1.8M $2.3M $2.4M $1.6M $1.4M $1.7M $1.7M $1.9M
Stockholders' Equity
Retained Earnings $-10.7M $-10.8M $-10.7M $-9.9M $-9.5M $-9.4M $-9.2M $-8.8M
Total Stockholders' Equity $-1.8M $-2.1M $-2.1M $-1.5M $-1.1M $-1.6M $-1.5M $-1.8M
← Newer Page 1 of 6 Older →